Organization (Details) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2025 USD ($) product	Jun. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2025 USD ($) product	Sep. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of commercial-stage products | product	3						3
Accumulated deficit	$ 399,540						$ 399,540		$ 392,815
Net loss	(5,074)	$ 553	$ 11,246	$ 901	$ 4,682	$ 3,862	6,725	$ 9,445
Cash and cash equivalents	100,403			$ 53,681			100,403	$ 53,681	$ 74,520
Investments	$ 84,600						$ 84,600